FMS Fresenius Medical Care AG
$22.50▼ -1.10%
Healthcare
Other
After hours
$22.50▲ +0.00%
Oct 27, 5:22 PM ET
Volume 781.0K
Avg Volume (10D) 1.48M
Key Metrics & Fundamentals
Market Cap
$11.97B
P/E Ratio
11.6
Div Yield
3.83%
52W Range
20.02 - 27.40
% vs 50 MA
0.27%
% vs 200 MA
-1.63%
RSI-14
54.3
MACD Histogram
+0.1700
Beta (1Y vs SPY)
0.17
Free Cash Flow
$619.90M
Gross Rev
$4.86B
Gross Profit
$1.31B
EBITDA
$873.82M
COGS
$3.55B
Operating Exp
$772.72M
Operating Income
$537.27M
EBIT
$537.27M
Pretax Income
$383.00M
Net Income
$218.38M
EPS (Diluted)
0.41
Price & Volume History
Loading chart…
Recent News
FMS Launches multiFiltratePRO System for U.S. Patients With Acute AKI
Zacks · Oct 23, 2026 9:55 AM ET
Fresenius Medical Care Brings Kidney Care Innovation to Critical Care Patients with U.S. Launch of multiFiltratePRO™
PR Newswire · Oct 21, 2026 6:05 PM ET
Fresenius Medical Care presents new evidence and innovations advancing kidney care at ASN Kidney Week 2026
PR Newswire · Oct 19, 2026 9:00 AM ET
Truist Trims Price Target on Fresenius Medical Care to $24 From $25, Keeps Hold Rating
MT Newswires · Oct 12, 2026 6:15 AM ET
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
Zacks · Oct 7, 2026 1:36 PM ET
Fresenius Medical Care Names Shervin Korangy as CEO, Board Chair
MT Newswires · Oct 7, 2026 11:31 AM ET
Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth
PR Newswire · Oct 7, 2026 11:28 AM ET
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading
MT Newswires · Sep 29, 2026 11:07 AM ET
Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth
Zacks · Sep 29, 2026 8:44 AM ET
Berenberg Downgrades Fresenius Medical Care to Hold From Buy, Cuts Price Target to $24 From $34.50
MT Newswires · Sep 29, 2026 6:32 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See FMS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.